News & Media

Press Releases

Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases, today announced the appointment of Pierre Legault, MBA, CPA as director and chairman of its board of directors…

Download a PDF: EN or FR

Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and Metabolic Diseases

Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and …

Download a PDF: EN or FR

Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate

Amolyt Pharma 3 announces that it has completed a €67 million Series A financing round …

Download a PDF: EN or FR

Upcoming events

Date: September 29 – October 3, 2021 (Virtual)

Learn more about the conference »

Date: October 2021

Date: October 1-4, 2021 (Toronto)

Learn more about the conference »

Date: October 13-16, 2021 (Le Havre)

Learn more about the conference »

Date: October 19-22, 2021 (Denver, CO)

Learn more about the conference »

Date: November 2-7, 2021 (San Diego, CA)

Learn more about the conference »

Date: November 1, 2021

Social Updates

TWITTER

Scroll to Top